Cargando…
Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator
• Malignant peritoneal mesothelioma is a rare aggressive tumor with approximately 400 new cases annually in the US. • In optimal cytoreduction HIPEC is the standard treatment. • In suboptimal cytoreduction IV cisplatin and pemetrexed have high efficacy.
Autores principales: | Grzankowski, Kassondra S., Brightwell, Rachel M., Kasznica, John M., Odusi, Kunle O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434159/ https://www.ncbi.nlm.nih.gov/pubmed/26076085 http://dx.doi.org/10.1016/j.gore.2014.11.002 |
Ejemplares similares
-
Poorly differentiated Sertoli–Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report
por: Brightwell, Rachel, et al.
Publicado: (2015) -
Malignant Peritoneal Mesothelioma Without Asbestos Exposure
por: Abbas, Hafsa, et al.
Publicado: (2019) -
Malignant Pleural and Peritoneal Mesothelioma Consequential to Brief Indirect Asbestos Exposure
por: Singhal, Bharati, et al.
Publicado: (2014) -
Malignant mesothelioma of the tunica vaginalis of the testis without exposure to asbestos
por: Goel, Ashish, et al.
Publicado: (2008) -
Malignant Mesothelioma after Household Exposure to Asbestos
por: Saba, Raya, et al.
Publicado: (2013)